BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines

cord CD34þ samples were received through the Normal Donor Repository in the Translational Core Laboratory at Cincinnati Children’s Research Foundation, which is supported through the NIDDK Center’s of Excellence in Experimental Hematology (P30DK090971). We thank the Mt Auburn Ob-Gyn associates and delivery nursing staff at the Christ Hospital (Cincinnati, OH, USA) for collecting cord blood (CD34þ ) samples from normal deliveries. We thank Jeff Bailey and Victoria Summey for assistance with transplantations and xenotransplantations (Comprehensive Mouse and Cancer Core). MDSL cells were kindly provided by Dr Kaoru Tohyama and are made available upon request (ktohyama@med.kawasaki-m.ac.jp or Daniel.Starczynowski@cchmc.org).